Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Dare Bioscience, Inc. - Common Stock (NQ:DARE)

2.691 -0.149 (-5.26%)
Streaming Delayed Price Updated: 1:12 PM EDT, Jul 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,091,733
Open 2.810
Bid (Size) 2.680 (5)
Ask (Size) 2.700 (2)
Prev. Close 2.840
Today's Range 2.630 - 2.840
52wk Range 2.110 - 9.190
Shares Outstanding 70,521,979
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks are being observed in Tuesday's session.
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
US Stocks Close Mixed As Tariff Concerns Rise: Investor Sentiment Improves, Fear & Greed Index Remains In 'Extreme Greed' Zone
Via Benzinga

Performance

YTD
-16.4%
-16.4%
1 Month
-9.4%
-9.4%
3 Month
-8.8%
-8.8%
6 Month
-19.4%
-19.4%
1 Year
-20.4%
-20.4%

More News

Read More
Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson (NYSE: MCK) Sends “FOCUSfactor” Exploding Across North America – More Stocks Inside
Via AB Newswire
These stocks are moving in today's session
Via Chartmill
Dare Bioscience's Earnings Outlook
Via Benzinga
Crude Oil Moves Lower; Daré Bioscience Shares Jump
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Unusual volume stocks in Monday's session
Via Chartmill
Which stocks are moving on Monday?
Via Chartmill
A Look Ahead: Dare Bioscience's Earnings Forecast
Via Benzinga
Insights into Dare Bioscience's Upcoming Earnings
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
US Stocks Edge Lower; Fastenal Posts Upbeat Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 31, 2025
Via Benzinga
Earnings Scheduled For May 13, 2025
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
DARE Stock Earnings: Dare Bioscience Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Via Benzinga
DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace

Frequently Asked Questions

Is Dare Bioscience, Inc. - Common Stock publicly traded?
Yes, Dare Bioscience, Inc. - Common Stock is publicly traded.
What exchange does Dare Bioscience, Inc. - Common Stock trade on?
Dare Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dare Bioscience, Inc. - Common Stock?
The ticker symbol for Dare Bioscience, Inc. - Common Stock is DARE on the Nasdaq Stock Market
What is the current price of Dare Bioscience, Inc. - Common Stock?
The current price of Dare Bioscience, Inc. - Common Stock is 2.691
When was Dare Bioscience, Inc. - Common Stock last traded?
The last trade of Dare Bioscience, Inc. - Common Stock was at 07/16/25 01:12 PM ET
What is the market capitalization of Dare Bioscience, Inc. - Common Stock?
The market capitalization of Dare Bioscience, Inc. - Common Stock is 189.74M
How many shares of Dare Bioscience, Inc. - Common Stock are outstanding?
Dare Bioscience, Inc. - Common Stock has 190M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.